SCHEMBL7974026

SCHEMBL7974026

NC(=O)c1c(N)ncn1Cc1cccc(Cl)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.58
ADRA1D P25100 2/20 0.52
ACP1 P24666 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
GLA P06280 1/20 0.46
HTT P42858 1/20 0.46
UBE2N P61088 1/20 0.46
PLA2G1B P04054 1/20 0.46
ATG4B Q9Y4P1 1/20 0.46
KMT2A Q03164 1/20 0.45
EGLN1 Q9GZT9 1/20 0.45
FSCN1 Q16658 1/20 0.45
GAA P10253 1/20 0.45
PKM P14618 1/20 0.45
TSHR P16473 1/20 0.45
YTHDC1 Q96MU7 3/20 0.44
MAPK1 P28482 1/20 0.44
ADORA2A P29274 1/20 0.43
ADORA1 P30542 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18050886 0.87 KDM4E (0.58) KDM4EADRA1DACP1SMN1; SMN2L3MBTL1
SCHEMBL5483136 0.86 PKM (0.59) ADRA1DACP1EGLN1GAAPKM
SCHEMBL7987743 0.85 SCD (0.50) ADRA1DACP1SMN1; SMN2HTTGAA
Hydrochloric Acid SCHEMBL7987445 0.85 PKM (0.57) ADRA1DACP1EGLN1GAAPKM
SCHEMBL7975372 0.84 ALDH1A1 (0.51) ADRA1DSMN1; SMN2HTTKMT2AGAA
SCHEMBL7974168 0.84 CDK9 (0.45) SMN1; SMN2L3MBTL1GAAPKMTSHR
SCHEMBL7984239 0.81 ADRA1D (0.52) ADRA1DKMT2AYTHDC1ADORA2AADORA1
SCHEMBL7974034 0.81 ATM (0.48) KDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL7988093 0.81 FYN (0.43) KDM4EL3MBTL1KMT2AGAAPKM
SCHEMBL28016885 0.80 ACP1 (0.53) KDM4EACP1SMN1; SMN2L3MBTL1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed